These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8316302)

  • 21. Cholesteryl ester transfer protein: an enigmatic protein.
    Moulin P
    Horm Res; 1996; 45(3-5):238-44. PubMed ID: 8964591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lipid transfer proteins.
    Tall A
    Annu Rev Biochem; 1995; 64():235-57. PubMed ID: 7574481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.
    Hayek T; Masucci-Magoulas L; Jiang X; Walsh A; Rubin E; Breslow JL; Tall AR
    J Clin Invest; 1995 Oct; 96(4):2071-4. PubMed ID: 7560101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
    Le Goff W; Guerin M; Chapman MJ
    Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
    de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
    Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats.
    Zak Z; Gautier T; Dumont L; Masson D; Deckert V; Duverneuil L; Pais De Barros JP; Le Guern N; Schneider M; Moulin P; Bataillard A; Lagrost L
    Atherosclerosis; 2005 Feb; 178(2):279-86. PubMed ID: 15694935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
    de Vries-van der Weij J; Zadelaar S; Toet K; Havekes LM; Kooistra T; Rensen PC
    Atherosclerosis; 2009 Sep; 206(1):153-8. PubMed ID: 19345354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of new antiatherosclerotic agents--ACAT inhibitors and CETP inhibitors].
    Miyazaki A; Horiuchi S
    Nihon Rinsho; 1999 Dec; 57(12):2842-7. PubMed ID: 10638223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
    Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
    J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice.
    Cazita PM; Berti JA; Aoki C; Gidlund M; Harada LM; Nunes VS; Quintão EC; Oliveira HC
    J Lipid Res; 2003 Jan; 44(1):33-40. PubMed ID: 12518020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice.
    Casquero AC; Berti JA; Salerno AG; Bighetti EJ; Cazita PM; Ketelhuth DF; Gidlund M; Oliveira HC
    J Lipid Res; 2006 Jul; 47(7):1526-34. PubMed ID: 16603720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice.
    Marotti KR; Castle CK; Murray RW; Rehberg EF; Polites HG; Melchior GW
    Arterioscler Thromb; 1992 Jun; 12(6):736-44. PubMed ID: 1591233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.
    Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1105-10. PubMed ID: 10195942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia.
    Fazio S; Marotti KR; Lee YL; Castle CK; Melchior GW; Rall SC
    J Biol Chem; 1994 Dec; 269(51):32368-72. PubMed ID: 7798236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.
    Masson D; Duverger N; Emmanuel F; Lagrost L
    J Biol Chem; 1997 Sep; 272(39):24287-93. PubMed ID: 9305883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.
    Huang Z; Inazu A; Nohara A; Higashikata T; Mabuchi H
    Clin Sci (Lond); 2002 Dec; 103(6):587-94. PubMed ID: 12444911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein.
    Dinchuk J; Hart J; Gonzalez G; Karmann G; Schmidt D; Wirak DO
    Biochim Biophys Acta; 1995 Apr; 1255(3):301-10. PubMed ID: 7734447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.